KD Logo

Ultragenyx Pharmaceutical Inc [RARE] EVP and Chief Medical Officer makes an insider purchase of 520 shares worth 20405.0.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ultragenyx Pharmaceutical Inc shares valued at $20,405 were sold by Crombez Eric on May 05 ’25. At $39.24 per share, Crombez Eric sold 520 shares. The insider’s holdings dropped to 71,530 shares worth approximately $2.57 million following the completion of this transaction.

Also, Crombez Eric sold 242 shares, netting a total of over 8,497 in proceeds. Following the sale of shares at $35.11 each, the insider now holds 71,680 shares.

Before that, Horn Howard had sold 1,785 shares from its account. In a trade valued at $72,114, the Chief Financial Officer traded Ultragenyx Pharmaceutical Inc shares for $40.40 each. Upon closing the transaction, the insider’s holdings decreased to 1,785 shares, worth approximately $3.82 million.

As published in a research note from Goldman on June 06, 2024, Ultragenyx Pharmaceutical Inc [RARE] has been rated up from a Neutral to a Buy and the price target has been revised to $67 from $56. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late April. As of December 08, 2023, Wells Fargo has initiated its “an Overweight” rating for RARE.

Analyzing RARE Stock Performance

During the last five days, there has been a drop of approximately -7.67%. Over the course of the year, Ultragenyx Pharmaceutical Inc shares have dropped approximately -14.48%. Shares of the company reached a 52-week high of $46.50 on 02/06/25 and a 52-week low of $29.59 on 04/09/25. A 50-day SMA is recorded $37.40, while a 200-day SMA reached $46.26.

Support And Resistance Levels for Ultragenyx Pharmaceutical Inc (RARE)

According to the 24-hour chart, there is a support level at 33.79, which, if violated, would cause prices to drop to 31.60. In the upper region, resistance lies at 37.51. The next price resistance is at 39.04. RSI (Relative Strength Index) is 46.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.39, which suggests the price will decrease in the coming days. Percent R is at 56.31%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular